Zachary Hill, PhD

Dr. Zachary B. Hill, PhD, is co-founder and CSO of Soteria Biotherapeutics. In this role, he oversees the company’s discovery research activities and leads scientific strategy. Prior to founding Soteria, Dr. Hill was a postdoctoral fellow at UCSF, where he co-invented Soteria’s LITE Switch technology. While at UCSF he was a Helen Hay Whitney Fellow, as well as the recipient of a NIH K99/R00 Transition Award from the NCI. Dr. Hill received his PhD in organic chemistry from the University of Washington, where he worked on the development of bivalent inhibitors of protein kinases. He has over 15 years of research experience focused at the interface of proteins and small molecules, with an emphasis on developing novel therapeutics.